⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14640060 | 0.72 | — | — | |
| Methane SCHEMBL16008272 | 0.62 | — | — | |
| SCHEMBL19894436 | 0.61 | — | — | |
| Water SCHEMBL28538081 | 0.55 | — | — | |
| SCHEMBL29015160 | 0.55 | — | — | |
| SCHEMBL25457582 | 0.50 | — | — | |
| SCHEMBL49765 | 0.47 | — | — | |
| Ethane SCHEMBL7169030 | 0.47 | — | — | |
| Ethane SCHEMBL28660153 | 0.47 | — | — | |
| Ethane SCHEMBL16975097 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355117-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118159271-A | Treatment of JAK inhibition responsive conditions with prodrugs of JAK inhibitors | 太阳医药工业公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118139851-A | Antitumor compounds | 法马马有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118076584-A | Esters of retinoids and bakuchiol and formulations thereof | 康纳根有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118055926-A | ROCK2 inhibitors and uses thereof | 哈佛大学的校长及成员们 | 2024-05-17 | — | — | CN | disclosed |
| CN-111433211-B | Synthesis of halichondrin | 哈佛大学的校长及成员们 | 2024-05-07 | — | — | CN | disclosed |
| CN-113444086-B | Ezh2 inhibitors and uses thereof | 达纳-法伯癌症研究所股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117924310-A | Macrocyclic compounds and uses thereof | 哈佛大学的校长及成员们 | 2024-04-26 | — | — | CN | disclosed |
| CN-117881395-A | Compositions for delivery of mRNA | 翻译生物公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-117580841-A | Macrocyclic compounds and uses thereof | 特修斯制药公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-111848940-A | Polycarbonate polyol compositions and methods | 沙特阿美技术公司 | 2020-10-30 | — | — | CN | disclosed |
| CN-111825611-A | 4(1H) -quinovone derivatives and uses thereof | 中央研究院 | 2020-10-27 | — | — | CN | disclosed |
| CN-111757735-A | Compounds for the treatment of kinase-dependent disorders | 埃克塞里艾克西斯公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-107266669-B | Polycarbonate polyol compositions and methods | 沙特阿美技术公司 | 2020-08-25 | — | — | CN | disclosed |
| CN-111479806-A | D-amino acid oxidase inhibitors and therapeutic uses thereof | 心悦生医股份有限公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-111263758-A | Branched multifunctional macromers and related polymers and uses thereof | 麻省理工学院 | 2020-06-09 | — | — | CN | disclosed |
| CN-111032655-A | EGFR and/or HER2 inhibitors and methods of use | 达纳-法伯癌症研究所股份有限公司 | 2020-04-17 | — | — | CN | disclosed |
| CN-110958882-A | Tricyclic compounds as glycogen synthase kinase 3(GSK3) inhibitors and uses thereof | 布罗德研究所股份有限公司 | 2020-04-03 | — | — | CN | disclosed |
| CN-106074591-B | RNA interference in ocular symptoms | 菲奥医药公司 | 2020-01-14 | — | — | CN | disclosed |
| CN-110621678-A | Antitumor compounds | 法马马有限公司 | 2019-12-27 | — | — | CN | disclosed |